These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6706270)

  • 1. [Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents].
    Estler CJ
    Fortschr Med; 1984 Feb; 102(6):129-32. PubMed ID: 6706270
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of psychotic symptoms associated with the disease and its treatments.
    Monias A; Samuels SC
    Geriatrics; 2001 Nov; 56(11):56-7. PubMed ID: 11710816
    [No Abstract]   [Full Text] [Related]  

  • 3. [Depressive syndrome, psychoses, dementia: frequent manifestations in Parkinson disease].
    Wedekind S
    MMW Fortschr Med; 2005 Jun; 147(22):11. PubMed ID: 15977623
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease.
    Tousi B; Subramanian T
    Parkinsonism Relat Disord; 2005 Aug; 11(5):333-4. PubMed ID: 15949966
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategies to modify levodopa treatment.
    Widner H
    Adv Neurol; 2003; 91():229-36. PubMed ID: 12442681
    [No Abstract]   [Full Text] [Related]  

  • 6. Safinamide (Newron Pharmaceuticals).
    Chazot PL
    Curr Opin Investig Drugs; 2001 Jun; 2(6):809-13. PubMed ID: 11572661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal selegiline (Emsam).
    Med Lett Drugs Ther; 2006 May; 48(1235):41-2. PubMed ID: 16770292
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug interactions in the treatment of Parkinson's disease.
    Jost WH; Brück C
    J Neurol; 2002 Oct; 249 Suppl 3():III/24-9. PubMed ID: 12522568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease.
    Anglès A; Bagheri H; Saivin S; Montastruc JL
    Therapie; 2002; 57(4):408-10. PubMed ID: 12422563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adverse effects of drug therapy in Parkinson disease].
    Gehlen W
    Med Monatsschr Pharm; 1980 Apr; 3(4):104-10. PubMed ID: 7464667
    [No Abstract]   [Full Text] [Related]  

  • 11. [Withdrawal of non-dopaminergic antiparkinson drugs].
    Le Bellec M; George V
    J Toxicol Clin Exp; 1985; 5(1):47-53. PubMed ID: 3843760
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug-induced neurologic disorders. I. Central nervous system (author's transl)].
    Manigand G
    Therapie; 1982; 37(2):113-41. PubMed ID: 6126015
    [No Abstract]   [Full Text] [Related]  

  • 13. A new gold standard. Pending drugs could slow progression of Parkinson's.
    Paul KJ
    Contemp Longterm Care; 1999 Feb; 22(2):53. PubMed ID: 10346510
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmaceutical care of Parkinson patients].
    Lennecke K
    Med Monatsschr Pharm; 2005 Jul; 28(7):228-36; quiz 237-8. PubMed ID: 16038120
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of the new antiepileptic drugs.
    Gidal BE
    Am J Manag Care; 2001 Jul; 7(7 Suppl):S215-20. PubMed ID: 11474770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiparkinsonian drugs and "sleep attacks".
    Moller H
    CMAJ; 2001 Apr; 164(7):1038-9, 1042-3. PubMed ID: 11314438
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion.
    van Laar T; Lammers GJ; Roos RA; Gerritsen JJ; Meinders AE
    Mov Disord; 1998 Jan; 13(1):176-8. PubMed ID: 9452348
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential nondopaminergic drugs for Parkinson's disease.
    Silverdale MA; Fox SH; Crossman AR; Brotchie JM
    Adv Neurol; 2003; 91():273-91. PubMed ID: 12442686
    [No Abstract]   [Full Text] [Related]  

  • 19. [Between Scylla and Charybdis: drug-induced psychosis in patients with Parkinson disease].
    Kuiper MA; Zwaan WA; Wolters EC
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1353-7. PubMed ID: 8035892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Side effects and toxic action of anti-epileptic drugs].
    Karkos J
    Pol Tyg Lek; 1972 Sep; 27(36):1411-5. PubMed ID: 4342781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.